Copyright
©The Author(s) 2016.
World J Gastroenterol. Nov 14, 2016; 22(42): 9300-9313
Published online Nov 14, 2016. doi: 10.3748/wjg.v22.i42.9300
Published online Nov 14, 2016. doi: 10.3748/wjg.v22.i42.9300
Target | Method /source | Affinity | Ref. |
sTNF | SPR | GOL = ETA > IFX > ADA | [40] |
sTNF | SPR | ETA > ADA = IFX | [41] |
mTNF | mTNF-expressing cells (Sp2/0-11A5-1 myeloma cells) | IFX = ADA = ETA | [41] |
mTNF | mTNF-expressing cells (K2 murine myeloma cells) | IFX = GOL > ADA > ETA | [40] |
mTNF | PBMCs (T cells) | IFX = ADA > Certo >> No binding of ETA | [42] |
Flow cytometry | |||
mTNF | PBL | IFX >> No binding of ETA | [43] |
Flow cytometry | |||
sTNF | Immunoassay | IFX > ETA (rapid dissociation) | [44] |
- Citation: Billmeier U, Dieterich W, Neurath MF, Atreya R. Molecular mechanism of action of anti-tumor necrosis factor antibodies in inflammatory bowel diseases. World J Gastroenterol 2016; 22(42): 9300-9313
- URL: https://www.wjgnet.com/1007-9327/full/v22/i42/9300.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i42.9300